Clinical research on the risk factors of Sarcopenia in diabetic patients

Clinical research on the risk factors of Sarcopenia in diabetic patients - Impact of diabetes mellitus on dynapenia study(iDIAMOND study)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020901

Enrollment

1500

Registered

2016-03-01

Start date

2016-03-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Sarcopenia, Dynapenia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type 1 and 2 Diabetes , non-diabetic, community-dwelling older

Exclusion criteria

Exclusion criteria: Patients with advanced cardiovascular, cerebrovascular and kindney disease. Patients receiving steroid treatment. Patients with gait dysfunction. Those for other reasons, who are decided as inadequate for subjects by their physician.

Design outcomes

Primary

Measure	Time frame
The relationship between skin autofluorescence, IGF-1, testosteron and limb skeletal muscle mass and knee extension strength(measurement of once a year).	—

Secondary

Measure	Time frame
The relationship between sarcopenia biomarker and age and diabetes factor(measurement of once a year).	—

Countries

Japan

Contacts

Public ContactMori Hiroyasu

Tokushima University Diabetes Therapeutics and Research Center

mori.hiroyasu@tokushima-u.ac.jp0886337587

Outcome results